In addition, GRPr-based imaging can play a complementary role to choline-based or PSMA-based imaging for full characterization of prostate cancer disease and biopsy guidance in low- and intermediate-metastatic-risk PCa patients and has the potential to discriminate them from those of higher risks. The gene discussed is FOLH1; the disease is prostate cancer.